JUL 17·Zacks CommentaryMed
Recursion Pharmaceuticals Rises 6% in a Month: How to Play the Stock
RXRX gains 5.5% in a month on positive pipeline update. long-term hold advised given strong potential of its AI-driven drug discovery platform.
StockHealthcare · Biotechnology
$RLYB
Rallybio Corp
Price · $RLYBvia TradingView
AI sentiment · 7d0 articles
No enriched coverage for $RLYB in the last 7 days.
Insider · 30dFeed →
No SEC Form 4 filings for $RLYB in the last 30 days.
Top stories · $RLYBMore →
JUL 8·Motley Fool
Here's Why Shares in Recursion Pharmaceuticals Surged Today
Shares in biotech company Recursion Pharmaceuticals ( NASDAQ: RXRX ) surged by more than 12% by 11 a.m. ET today. The move is due to a de-risking event in its drug discovery pipeline.The de-risking event relates to the acquisition of the 50% interest in an ENPP1 inhibitor program ( REV102 ) that ...
JUL 8·Benzinga
Why Is Microcap Rallybio Stock Trading Higher On Tuesday? - Rallybio ( NASDAQ:RLYB ) , Recursion Pharmaceuticals ( NASDAQ:RXRX )
Rallybio receives $7.5 million upfront equity and is eligible for $17.5 million in future milestone payments. The cash runway is now extended into mid-2027 following the asset sale. From tariffs to inflation, macro risks are rising-Matt Maley reveals how he's trading it all, live this Wednesday ...